Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belumosudil and Ruxolitinib Combination for cGvHD (BELRUX)
NCT07643025Phase 2Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
A Phase 2 trial of belumosudil in chronic graft-versus-host disease (cGVHD). Planned start Nov 2026; status: not yet recruiting.
02
Drugs
belumosudil
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT07643025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07643025.